#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extra-osseous Ewing's sarcoma Sexually transmitted disease Encephalitis autoimmune Adult T-cell lymphoma/leukaemia refractory Alport's syndrome Mucopolysaccharidosis I Progressive supranuclear palsy Mantle cell lymphoma recurrent Ataxia telangiectasia Infantile apnoea Mycobacterium abscessus infection HER2 mutant non-small cell lung cancer Hereditary motor and sensory neuropathy Sarcoidosis Acute graft versus host disease More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Basic Information Mucopolysaccharidosis I – Treatment Fragile X syndrome – Life with Disease Synovial sarcoma – Trials in Disease Pelizaeus-Merzbacher disease – Basic Information Idiopathic pulmonary fibrosis Langerhans’ cell histiocytosis – Basic Information Retinoblastoma – Treatment Pituitary-dependent Cushing’s syndrome – Diagnostics Angiosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Resomelagon VOTOPLAM ZELENECTIDE PEVEDOTIN Tamuzimod Acetate Sodium Chloride Phosphocreatine Sodium Pacritinib Adrc VENT-03 Cemiplimab Atl001 Anhydrous Caffeine Poa Pratensis IM-101 Prednisolone Betamethasone Sodium Phosphate Fludrocortisone Linezolid Dexmedetomidine Atomoxetine Hydrochloride More therapies…

    Learn about Your Condition

    Lymphocytic leukaemia Mantle cell lymphoma stage II Chondrosarcoma metastatic Myxofibrosarcoma Alveolar rhabdomyosarcoma Cervix carcinoma stage IV Seizure Neutropenia Meningorrhagia Fragile X syndrome Hepatic encephalopathy Anal abscess Complex regional pain syndrome Adenomatous polyposis coli Autoimmune haemolytic anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciprofloxacin Hydrochloride Monohydrate
    • Clindamycin
    • Levofloxacin
    The Netherlands

  • Study on Tocilizumab and Prednisolone for Arthritis Caused by Cancer Immunotherapy in Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Eastern Cooperative Oncology Group performance status
    Investigated Drugs:
    • Tocilizumab
    • Prednisolone
    France Sweden

  • Study on the Safety and Effectiveness of TransCon CNP for Children and Adolescents with Achondroplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Austria Denmark Finland France Germany Ireland +4

  • Study on Nipocalimab for Children Aged 2-17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Nipocalimab
    The Netherlands Poland

  • Study on Treating Adynamic Bone Disorder with Teriparatide in Patients with Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Teriparatide
    Denmark

  • Study on the Use of Romosozumab and Zoledronic Acid for Treating Osteoporosis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Zoledronic Acid
    • Romosozumab
    Denmark
Previous Page
1 … 25 26 27 28 29 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!